^
Association details:
| Biomarker: | TSC2 mutation |
|---|---|
| Cancer: | Pancreatic Cancer |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report
Published date:
11/22/2021
Excerpt:
In this case, the effect of immunotherapy combined with chemotherapy seems to be very effective. We also established a hypothesis that the SMAD4 and TSC2 mutations improved the efficacy of immunotherapy, prolonging the survival of patients.
DOI:
10.3389/fimmu.2021.785400
